A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
Public ClinicalTrials.gov record NCT03740919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The reason for this study is to compare the study drug LY900014 to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).
Study identification
- NCT ID
- NCT03740919
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 751 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 1 Year to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 7, 2019 (Actual)
- Primary completion
- Jul 2, 2021 (Actual)
- Completion
- Jul 2, 2021 (Actual)
- Last update posted
- Jan 24, 2022
2019 – 2021
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Birmingham | Birmingham | Alabama | 35233 | — |
| University of Arizona | Tucson | Arizona | 85724 | — |
| Children's Hospital Los Angeles - Dept of Endocrinology | Los Angeles | California | 90027 | — |
| Stanford University School of Medicine - Division of Pediatric Endocrinology & Diabetes | Palo Alto | California | 94304 | — |
| Center of Excellence in Diabetes & Endocrinology | Sacramento | California | 95821 | — |
| Rady Childrens Hospital - San Diego | San Diego | California | 92123 | — |
| Barbara Davis Center | Aurora | Colorado | 80045 | — |
| Florida Hospital | Orlando | Florida | 32803 | — |
| Tallahassee Memorial HealthCare | Tallahassee | Florida | 32308 | — |
| University of South Florida Diabetes & Endocrinology Center | Tampa | Florida | 33612 | — |
| VanMeter Pediatric Endocrinology, P.C. | Atlanta | Georgia | 30318 | — |
| St. Luke's Children's Endocrinology | Boise | Idaho | 83704 | — |
| Rocky Mountain Diabetes and Osteoporosis Center | Idaho Falls | Idaho | 83404 | — |
| Indiana University- Riley Children's Hospital | Indianapolis | Indiana | 46202 | — |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50265 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808-4124 | — |
| Barry Reiner Clinic | Baltimore | Maryland | 21229 | — |
| Joslin Diabetes Center | Boston | Massachusetts | 02215 | — |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| UBMD Pediatrics | Buffalo | New York | 14203 | — |
| Suny Health Science Center at Syracuse | Syracuse | New York | 13210 | — |
| Endocrinology Services NorthWest | Bend | Oregon | 97702 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Texas Diabetes & Endocrinology, P.A. | Austin | Texas | 78731-4309 | — |
| Texas Institute for Kidney and Endocrine Disorders | Lufkin | Texas | 75904 | — |
| Diabetes and Glandular Disease Research Associates PA | San Antonio | Texas | 78229 | — |
| MultiCare Institute for Research & Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03740919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2022 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03740919 live on ClinicalTrials.gov.